FCP
RBOT

Fidelis Capital Partners’s Vicarious Surgical RBOT Stock Holding History

Fidelis Capital Partners’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-849
Closed -$7.68K – 397
2024
Q1 		$7.68K Buy
+849
New +$10.1K ﹤0.01% 378

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelis Capital Partners's RBOT Position: Q2 2024 in Review

Fidelis Capital Partners sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 849 shares — an estimated $7.68K sold.

Fidelis Capital Partners first reported a position in RBOT in Q1 2024 and held it in 1 quarter. The position peaked at $7.68K in Q1 2024. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • Fidelis Capital Partners reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • Fidelis Capital Partners sold 849 Vicarious Surgical shares in Q2 2024, an estimated $7.68K.
  • Fidelis Capital Partners first reported a position in Vicarious Surgical in Q1 2024 and held it in 1 quarter.
  • Fidelis Capital Partners's Vicarious Surgical position peaked at $7.68K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on Fidelis Capital Partners's 13F filing for Q2 2024, filed 13 Aug 2024.